Press ReleasesPureForm Global Secures European Food Safety Authority Novel Food...

PureForm Global Secures European Food Safety Authority Novel Food Validation


PureForm Global Inc, through its UK subsidiary PureForm International Ltd, has become the only UK CBD manufacturer to receive validation from the European Commission and the European Food Safety Authority for its Novel Food application.

As European authorities continue to introduce regulations to the CBD market place, PureForm CBD® is the first and only UK CBD manufacturing company producing CBD for sale as a raw ingredient to receive a Validated Novel Food Application from the European Food Safety Authority (EFSA). 

This means that PureForm is in pole position to be amongst the first CBD companies in the world to be granted the much sought after Novel Food License in the EU.

The purpose of the Novel Food application is to ensure safety by way of clinical studies and compliance within the CBD industry so consumers can have access to safe CBD and purchase products with confidence. 

Prior to Novel Foods Regulation, the CBD market had been a relatively poorly regulated sector. The validation of the PureForm CBD® dossier in the EU upholds its position as a leader in the market and goes beyond the industry standard.

Commenting on the validation of their dossier, COO of PureForm Global, Steve Miller said, “At a time when regulators are making it increasingly difficult for companies to import CBD into Europe, we are glad that our production facility in England will be able to supply both the UK and Europe with the highest quality CBD.  The validation from the EFSA is a great boost for our clients and ourselves.”

PureForm CBD® is synthetically produced which means it exceeds the increasingly rigorous standards being required by the Home Office.  

As explained by David McCormick, Head of European Operations, “Saying you have 0% THC (tetrahydrocannabinol) means nothing if you have only tested to parts per thousand. 

We test to parts per million, meaning that even if the Home Office changes to a level of 0.001% THC, our product still meets this standard. This is an exciting first step. But during the second half of the year, we are looking forward to expanding our European offering to include both CBG and CBC, with five additional cannabinoids coming on stream in 2022. We intend to submit Novel Food applications for all of these in due course.


Please enter your comment!
Please enter your name here

Latest news

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover...

Columbia Care Platinum Joins Forces With Poppy Jamie

Leading organic, vegan and regeneratively-farmed, plant-based CBD brand, Columbia Care Platinum(, announces it has teamed up with Poppy Jamie, mental wellbeing...

InterCure Announces European Expansion with International Cannabis Brand Cookies

InterCure Ltd. today announced its international expansion into Europe through a partnership with iconic cannabis brand Cookies. The parties entered...

Groups From 56 Countries Ask UN To Ensure Secretive ‘Cannabis Initiative’ Is Open To Public Scrutiny

ONE year on from the formal recognition of the potential for cannabis as a medicine almost 200 global advocacy...

The New Common Agricultural Policy Has Been Adopted And the Maximum THC Level on the Field Has Been Restored to 0.3%

It was in October 2020 when we announced that the European Parliament had voted in favour of restoring the...

European Medical Cannabis Tech Accelerator Opens Call for Submissions

The first and only hybrid tech accelerator in Europe dedicated to the medical cannabis industry offers €100,000 grant to early-stage startups from around the world.

Must read

High-Profile Director Quits Oxford Cannabinoid Technologies Board Following Chairman’s Recent Departure

Oxford Cannabinoid Technologies (OCT) has seen its second senior...

You might also likeRELATED
Recommended to you